Research field (2):
Biomaterials
, Biomedical engineering
Research keywords (3):
遺伝子治療
, イメージング
, 抗癌剤
Research theme for competitive and other funds (1):
2008 - 2010 Establishment of early phase dynamic imaging for therapeutic effect of chemotherapeutic agents
Papers (75):
Sho Sato, Takashi Suzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, et al. Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases. Journal of gastroenterology. 2024
Sho Sato, Takashi Ssuzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, et al. The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study. International journal of clinical oncology. 2024
Sho Sato, Chikara Kunisaki, Yuko Tamura, Akikazu Yago, Kohei Kasahara, Tsutomu Sato, Hiroki Kondo, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo. Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601). Anticancer research. 2023. 43. 12. 5663-5670
Kohei Kasahara, Chikara Kunisaki, Sho Sato, Hiroki Kondo, Masazumi Takahashi, Yuko Tamura, Nobuhiro Tsuchiya, Yusaku Tanaka, Kei Sato, Jun Kimura, et al. Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer. Anticancer research. 2023. 43. 6. 2841-2850